Skip to main content
HR 2276 112th Congress House Commerce Congressional oversight Genetics Government studies and investigations Health care costs and insurance Health care coverage and access Health care quality Intellectual property Medical tests and diagnostic methods

To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive…

Show full title

To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.

Introduced: June 22, 2011 Introduced by: Wasserman Schultz, Debbie Democratic · Florida See on congress.gov
Sign in to write a letter Sign in to watch
This bill died when the 112th Congress ended
It never became law before the 112th Congress (2011–2012) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Aug 25, 2011
Referred to the Subcommittee on Intellectual Property, Competition and the Internet.
Jun 22, 2011
Referred to the Subcommittee on Health.
Jun 22, 2011
Referred to the Committee on the Judiciary, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 22, 2011
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Plain-English summary Congressional Research Service

Directs the Under Secretary of Commerce for Intellectual Property and Director of the U.S. Patent and Trademark Office (USPTO) to: (1) study ways to provide independent, confirming genetic diagnostic test activity where gene patents and exclusive licensing for primary genetic diagnostic tests exist; and (2) report the findings to Congress within nine months along with recommendations for establishing the availability of such independent confirming genetic diagnostic test activity.

Defines “confirming genetic diagnostic test activity” as the performance of a genetic diagnostic test, by a genetic diagnostic test provider, on an individual solely for the purpose of providing the individual with an independent confirmation of results obtained from another test provider’s prior performance of the test on the individual.

What's happening now August 25, 2011

Referred to the Subcommittee on Intellectual Property, Competition and the Internet.

 Related & companion bills 1
  • HR 1249 Related bill Leahy-Smith America Invents Act
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 4
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 2276: To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.. 112th Congress. Open America. https://openamerica.io/bill/112-HR-2276/
MLA
"H.R. 2276: To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.." 112th Congress, 2026, Open America, https://openamerica.io/bill/112-HR-2276/.
Bluebook (legal)
H.R. 2276, 112th Cong. (2026), https://openamerica.io/bill/112-HR-2276/.
Markdown link
[H.R. 2276: To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.](https://openamerica.io/bill/112-HR-2276/)
Report a problem